Kallikrein‐related peptidase 10 (KLK10) is homologue to KLK3 and encodes the prostate‐specific antigen, which is a widely used biomarker for the detection and monitoring of prostate cancer (Sardana et al., 2007). This evidence concerns the gene KLK3 and prostate carcinoma.